2017
DOI: 10.1002/14651858.cd012885
|View full text |Cite
|
Sign up to set email alerts
|

Non-nutritive sweeteners for diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 45 publications
0
11
0
1
Order By: Relevance
“…Based on the available evidence, it is difficult to determine conclusively whether NNS affect the risk of diabetes in humans [ 44 ]. Some studies report no effect on insulin and glucose.…”
Section: Sweet Taste Perceptionmentioning
confidence: 99%
“…Based on the available evidence, it is difficult to determine conclusively whether NNS affect the risk of diabetes in humans [ 44 ]. Some studies report no effect on insulin and glucose.…”
Section: Sweet Taste Perceptionmentioning
confidence: 99%
“…Given this extensive literature on mechanisms, one might expect that there is an equally large and convincing body of evidence demonstrating the adverse effects of LES on humans, prompting the need for mechanistic understanding and explanations. Yet, every recent systematic review (SR) and meta-analysis of randomised controlled trials (RCTs) in humans—from acute studies of appetite and glycaemic responses through longer-term studies with anthropometric and glycaemic control endpoints—finds neutral or beneficial effects of LES, and almost no indications of adverse effects on these outcomes [ 2 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ]. Thus, the stream of papers offering a multitude of mechanisms for the adverse effects of LES exists within the context of a wall of empirical evidence that fails to find any adverse effects to be explained.…”
Section: Perspectivementioning
confidence: 99%
“…Despite a number of significant shortcomings in that research [ 22 , 23 ], this single paper set off a stampede of research funding and activity on LES and the microbiota, and left much of the scientific community presuming that the original premise was simply true. Yet, the supposedly explained phenomenon (i.e., LES producing impaired glycaemic control) has no empirical support from comprehensive systematic reviews of the evidence [ 9 , 13 , 14 , 17 , 18 , 24 , 25 ]. This fact by itself should render the supposed “mechanism” specious, while years of subsequent research have also left doubt on the replicability of the initial research and basic premise that LES cause important, pathological changes in the gut microbiota [ 12 , 19 , 23 , 26 ].…”
Section: Perspectivementioning
confidence: 99%
“…Kaloria-murrizketan edota karbohidratoen banaketa zehatzetan oinarritutako dietez gain, badira beste erreminta terapeutikoak ere t2D duten pazienteekin erabiltzen direnak. Horien artean sakarosa edo etxeko azukre arrunta (lotura glukosidikoz elkartutako glukosaz eta fruktosaz osatutako disakaridoa) gozagarri ez-nutritiboengatik ordezkatzea izaten da aukera bat, zeinak mahaiko azukreak baino ahalmen gozagarri handiagoa baitute kaloria ekarpen baxuagoarekin [9]. Aurrekoez gain, aspalditik erabili den sakarosaren beste ordezkoa fruktosa izan da, zeinak, glukosak ez bezala, ez duen intsulinarik behar xurgatua/metabolizatua izateko, eta, ondorioz, ez duen odoleko glukosa-mailen handipenik eragiten [10].…”
Section: Sarreraunclassified